These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 6385586)

  • 41. Effect of PGE2 on sulfonylurea induced insulin release.
    Villar A; Ivorra MD; Anselmi E
    J Physiol (Paris); 1987; 82(1):12-7. PubMed ID: 3123643
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Extrapancreatic effects of oral sulfonylureas].
    Beyer J; Cordes U; Krall H; Rosak C; Schöffling K
    Verh Dtsch Ges Inn Med; 1971; 77():539-43. PubMed ID: 5155894
    [No Abstract]   [Full Text] [Related]  

  • 43. Mechanisms of fasting-induced increase in insulin binding to rat adipocytes.
    Olefsky JM; Kobayashi M
    J Clin Invest; 1978 Feb; 61(2):329-38. PubMed ID: 621276
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Glucose ingestion mediates a rapid increase in the insulin responsiveness of rat adipocytes.
    Livingston JN; Moxley RT
    Endocrinology; 1982 Nov; 111(5):1749-51. PubMed ID: 6751802
    [No Abstract]   [Full Text] [Related]  

  • 45. Effect of physiological concentrations of insulin and antidiabetic drugs on RNA release from isolated liver nuclei.
    Schumm DE; Webb TE
    J Cell Biochem; 1983; 23(1-4):223-9. PubMed ID: 6373797
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effect of oral sulphonylureas on blood glucose and insulin.
    Adadevoh BK; Bolodeoku JO
    Ghana Med J; 1973 Dec; 12(4):360-5. PubMed ID: 4282692
    [No Abstract]   [Full Text] [Related]  

  • 47. A comparison of cellular actions between gliclazide and a hypoglycaemic peptide fragment of human growth hormone (hGH 6-13).
    Ng FM
    Diabetes Res Clin Pract; 1988 May; 5(1):17-24. PubMed ID: 3042343
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of the in vitro effect of biguanides and sulfonylureas on insulin binding of its receptors in target cells.
    Vigneri R; Pezzino V; Wong KY; Goldfine ID
    J Clin Endocrinol Metab; 1982 Jan; 54(1):95-100. PubMed ID: 7033271
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Circadian stage dependent 125I-insulin binding in the liver and epididymal fat of the mouse.
    Feuers RJ; Hunter JD; Tsai TH; Cardoso SS; Scheving LE
    Prog Clin Biol Res; 1990; 341A():529-34. PubMed ID: 2217272
    [No Abstract]   [Full Text] [Related]  

  • 50. Effects of sulfonylureas on the actions of insulin and insulin-mimickers: potentiation of stimulated hexose transport in adipocytes.
    Maloff BL; Drake L; Riedy DK; Lockwood DH
    Eur J Pharmacol; 1984 Sep; 104(3-4):319-26. PubMed ID: 6389157
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sulfonylureas activate glucose transport and protein kinase C in rat adipocytes.
    Farese RV; Ishizuka T; Standaert ML; Cooper DR
    Metabolism; 1991 Feb; 40(2):196-200. PubMed ID: 1899124
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of tolbutamide & insulin on lipoprotein lipase activity.
    Augusti KT; Kurup PA
    Indian J Biochem; 1967 Mar; 4(1):56-7. PubMed ID: 4228206
    [No Abstract]   [Full Text] [Related]  

  • 53. [Effect of tolbutamide on the activity of transglutaminase].
    Coves MJ; Casanovas A; Sarto A; Casamitjana R; Gomis R; Vilardell E
    Rev Esp Fisiol; 1988 Mar; 44(1):7-11. PubMed ID: 2902666
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Effect of the sulfonylurea HB 419 (glibenclamide), tolbutamide and tolazamide on the lipolysis of isolated human fat cells].
    Faulhaber JD; Ditschuneit H; Ditschuneit HH
    Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1476-8. PubMed ID: 5394469
    [No Abstract]   [Full Text] [Related]  

  • 55. Extrapancreatic action of the sulphonylurea gliquidone: post-receptor effect on insulin-stimulated glycogen synthesis in rat hepatocytes in primary culture.
    Rinninger F; Kirsch D; Häring HU; Kemmler W
    Diabetologia; 1984 Jun; 26(6):462-5. PubMed ID: 6381193
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Mechanism of action of AR 3-ARDF 26, a new betacytotropic sulfonylurea derivative and tolbutamide].
    Zilker T; Bottermann P
    Verh Dtsch Ges Inn Med; 1972; 78():1275-8. PubMed ID: 4665516
    [No Abstract]   [Full Text] [Related]  

  • 57. Binding of sulfonylurea derivatives to bovine serum albumin: part I. Binding of SPC--703, tolbutamide, glibornuride and glipizide.
    Wójcikowski C; Szlabowicz D
    Pol J Pharmacol Pharm; 1977; 29(5):469-75. PubMed ID: 22846
    [No Abstract]   [Full Text] [Related]  

  • 58. Reversible reduction of insulin receptor affinity by ATP depletion in rat adipocytes.
    Steinfelder HJ; Joost HG
    Biochem J; 1983 Jul; 214(1):203-7. PubMed ID: 6351848
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Effect of adrenalectomy and hydrocortisone on insulin receptors of rat fat cell plasma membranes].
    Bezdrobnyĭ IuV; Evdokimova NIu; Efimov AS; Iatsyk MI
    Ukr Biokhim Zh (1978); 1983; 55(5):529-33. PubMed ID: 6636314
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Insulin-receptor interactions. Possible involvement of metals.
    Monreal JI; Viader C; Pérez-Barquero C; López-Moratalla N; de Pablo P; Santiago E
    Rev Esp Fisiol; 1987 Jun; 43(2):133-40. PubMed ID: 3310150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.